CNADF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Apr 10 closing price
Capitalization
3.98M
CPHI
Price
$1.87
Change
-$0.08 (-4.10%)
Updated
Sep 26 closing price
Capitalization
6.11M
Interact to see
Advertisement

CNADF vs CPHI

Header iconCNADF vs CPHI Comparison
Open Charts CNADF vs CPHIBanner chart's image
CANADABIS CAP
Price$0.06
Change-$0.00 (-0.00%)
Volume$6K
Capitalization3.98M
China Pharma Holdings
Price$1.87
Change-$0.08 (-4.10%)
Volume$7.83K
Capitalization6.11M
CNADF vs CPHI Comparison Chart in %
Loading...
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNADF vs. CPHI commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNADF is a Hold and CPHI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CNADF: $0.06 vs. CPHI: $1.87)
Brand notoriety: CNADF and CPHI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CNADF: 100% vs. CPHI: 12%
Market capitalization -- CNADF: $3.98M vs. CPHI: $6.11M
CNADF [@Pharmaceuticals: Generic] is valued at $3.98M. CPHI’s [@Pharmaceuticals: Generic] market capitalization is $6.11M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNADF’s FA Score shows that 1 FA rating(s) are green whileCPHI’s FA Score has 0 green FA rating(s).

  • CNADF’s FA Score: 1 green, 4 red.
  • CPHI’s FA Score: 0 green, 5 red.
According to our system of comparison, CPHI is a better buy in the long-term than CNADF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNADF’s TA Score shows that 1 TA indicator(s) are bullish while CPHI’s TA Score has 6 bullish TA indicator(s).

  • CNADF’s TA Score: 1 bullish, 0 bearish.
  • CPHI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CPHI is a better buy in the short-term than CNADF.

Price Growth

CNADF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while CPHI (@Pharmaceuticals: Generic) price change was -5.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPHI($6.11M) has a higher market cap than CNADF($3.98M). CNADF YTD gains are higher at: 78.571 vs. CPHI (-19.398). CNADF has higher annual earnings (EBITDA): 1.54M vs. CPHI (-1.74M). CNADF has more cash in the bank: 948K vs. CPHI (625K). CPHI has less debt than CNADF: CPHI (3.43M) vs CNADF (9.18M). CNADF has higher revenues than CPHI: CNADF (17.2M) vs CPHI (4.4M).
CNADFCPHICNADF / CPHI
Capitalization3.98M6.11M65%
EBITDA1.54M-1.74M-89%
Gain YTD78.571-19.398-405%
P/E Ratio11.57N/A-
Revenue17.2M4.4M391%
Total Cash948K625K152%
Total Debt9.18M3.43M268%
FUNDAMENTALS RATINGS
CPHI: Fundamental Ratings
CPHI
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNADFCPHI
RSI
ODDS (%)
Bullish Trend 3 days ago
40%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
29%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
33%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCAR100.504.93
+5.16%
PACCAR
BLBX6.270.19
+3.14%
Blackboxstocks
SCSC44.200.32
+0.73%
ScanSource
CNX32.230.06
+0.19%
CNX Resources Corp
FSFG31.81-0.65
-2.00%
First Savings Financial Group

CNADF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with CHSYF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then CHSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
CHSYF - CNADF
38%
Loosely correlated
N/A
ZTS - CNADF
24%
Poorly correlated
+1.68%
CPHI - CNADF
20%
Poorly correlated
-3.90%
ESAIY - CNADF
5%
Poorly correlated
-0.23%
HLNCF - CNADF
4%
Poorly correlated
-3.57%
More

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and ASRT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and ASRT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
-3.90%
ASRT - CPHI
25%
Poorly correlated
-4.33%
SXTC - CPHI
22%
Poorly correlated
+2.52%
MKKGY - CPHI
21%
Poorly correlated
+0.81%
AYTU - CPHI
21%
Poorly correlated
-6.45%
HCM - CPHI
21%
Poorly correlated
-0.95%
More